{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:53:53Z","timestamp":1753883633741,"version":"3.41.2"},"reference-count":22,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Primary malignant lymphomas originating in the adrenal gland, particularly of T-cell origin, are extremely rare. Here we present the primary unilateral adrenal anaplastic large cell lymphoma case. A 64-year-old Japanese male initially presented with fatigue and appetite loss. Computed tomography imaging revealed a unilateral adrenal mass with multiorgan invasion, posing challenges in differentiation from adrenal carcinoma. A biopsy from the metastatic site in the right lateral vastus muscle was obtained, and immunohistochemistry revealed that tumor cells were positive for CD30 and CD56 and negative for CD3, CD15, CD20, CD43, perforin, granzyme B, epithelial membrane antigen, and anaplastic lymphoma kinase. Ultimately, the patient was diagnosed with primary unilateral adrenal anaplastic large cell lymphoma. Although he achieved complete response to chemotherapy, he died 4 months after complete response due to cholecystitis and lymphoma recurrence.<\/jats:p>","DOI":"10.1210\/jcemcr\/luae229","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:49:45Z","timestamp":1733867385000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Unilateral Adrenal Anaplastic Large Cell Lymphoma: Remission by Chemotherapy"],"prefix":"10.1210","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3784-968X","authenticated-orcid":false,"given":"Daisuke","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-1931","authenticated-orcid":false,"given":"Yumie","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4723-6156","authenticated-orcid":false,"given":"Hisanori","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa 920-8640 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"4","key":"2024121021101900000_luae229-B1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1532\/IJH97.04143","article-title":"A case of adolescent primary adrenal natural killer cell lymphoma","volume":"81","author":"Mizoguchi","year":"2005","journal-title":"Int J Hematol"},{"issue":"12)","key":"2024121021101900000_luae229-B2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00277-013-1812-3","article-title":"Primary adrenal lymphoma: a systematic review","volume":"92","author":"Rashidi","year":"2013","journal-title":"Ann Hematol"},{"issue":"1","key":"2024121021101900000_luae229-B3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12902-023-01496-y","article-title":"Primary adrenal diffuse large B cell lymphoma with tumor thrombus in central adrenal vein: a case report and literature review","volume":"23","author":"Xing","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"2024121021101900000_luae229-B4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0046-8177(86)80136-8","article-title":"Primary T-cell lymphoma of the adrenal glands with adrenal insufficiency","volume":"17","author":"Schnitzer","year":"1986","journal-title":"Hum Pathol"},{"issue":"3-4","key":"2024121021101900000_luae229-B5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10428199709039025","article-title":"Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity","volume":"24","author":"Pimentel","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2024121021101900000_luae229-B6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-5347(01)62931-8","article-title":"Primary adrenal nonHodgkin's lymphoma: long-term survival","volume":"160","author":"May","year":"1998","journal-title":"J Urol"},{"issue":"4","key":"2024121021101900000_luae229-B7","first-page":"395","article-title":"Bilateral adrenal lymphoma presenting as Addison's disease and hypercalcaemia","volume":"17","author":"Oppong","year":"1991","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"2024121021101900000_luae229-B8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1349-7006.2002.tb02168.x","article-title":"Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland","volume":"93","author":"Nakatsuka","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"2024121021101900000_luae229-B9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/1042819021000047047","article-title":"Primary adrenal lymphoma","volume":"44","author":"Xu","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2024121021101900000_luae229-B10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ando.2007.12.002","article-title":"Primary bilateral adrenal T-cell lymphoma. A case report rarer than B-cell lymphoma","volume":"69","author":"Sfaxi","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"2024121021101900000_luae229-B11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5045\/br.2017.52.3.227","article-title":"Primary adrenal T-cell lymphoma in a young adult presented with pseudo-hypopyon: a case report and literature review","volume":"52","author":"Bommannan","year":"2017","journal-title":"Blood Res"},{"key":"2024121021101900000_luae229-B12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amsu.2020.11.066","article-title":"Intraocular T-cell lymphoma metastasizing from a primary adrenal T-cell lymphoma: case report","volume":"60","author":"Bedaiwi","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"2024121021101900000_luae229-B13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1746-1596-7-114","article-title":"NK\/T-cell lymphoma of bilateral adrenal glands in a patient with pyothorax","volume":"7","author":"Tsukahara","year":"2012","journal-title":"Diagn Pathol"},{"issue":"8","key":"2024121021101900000_luae229-B14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ajh.20856","article-title":"Primary adrenal adult T-cell leukemia\/lymphoma: a case report and review of the literature","volume":"82","author":"Tomoyose","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"2024121021101900000_luae229-B15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1092-9134(00)90039-X","article-title":"Primary anaplastic large cell lymphoma of the adrenal gland","volume":"4","author":"Frankel","year":"2000","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"2024121021101900000_luae229-B16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2024121021101900000_luae229-B17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jviscsurg.2017.06.010","article-title":"Surgical treatment of adrenal carcinoma","volume":"154","author":"Gaujoux","year":"2017","journal-title":"J Visc Surg"},{"issue":"4","key":"2024121021101900000_luae229-B18","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"2018 European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024121021101900000_luae229-B19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-13-1033","article-title":"Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome","volume":"170","author":"Williams","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024121021101900000_luae229-B20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0104-4230(11)70019-7","article-title":"World Health Organization classification of tumors of hematopoietic and lymphoid tissues, 2008\u2013major changes from the 3rd edition, 2001","volume":"57","author":"Zerbini","year":"2011","journal-title":"Rev Assoc Med Bras"},{"issue":"3","key":"2024121021101900000_luae229-B21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.annonc.2021.12.002","article-title":"The ECHELON-2 trial: 5-year results of a randomized, phase III study of Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","volume":"33","author":"Horwitz","year":"2022","journal-title":"Ann Oncol"},{"key":"2024121021101900000_luae229-B22","first-page":"2574","article-title":"Primary adrenal lymphoma: when the attempt to cure becomes the way to make diagnosis. Case report and systematic review of the literature","volume":"04","author":"Mazzola","year":"2018","journal-title":"J Oncol Res Ther"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/12\/luae229\/60966278\/luae229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/12\/luae229\/60966278\/luae229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:49:54Z","timestamp":1733867394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luae229\/7917926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11,7]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luae229","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,11,7]]},"article-number":"luae229"}}